PhD Student
Claudio obtained his master’s degree in Pharmaceutical Chemistry and Technology at the University of Milan in 2019 and he is currently a PhD student in Pharmaceutical Sciences at the same university where he is committed to the investigation and development of novel disease-modifying approaches to multiple sclerosis.